The German pharmaceutical-and-agricultural group stated that the deal goals to enhance its ophthalmology pipeline.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Related Posts
Airlines Are Already Preparing for an Oil Crisis
The battle with Iran and ensuing blockade within the Strait of Hormuz, a crucial transport lane, has spiked oil prices…
SpaceX needs to achieve 2 of its moonshots to keep valuation: Steve Westly
SpaceX workers go to work on the SpaceX facility in Hawthorne on the day of their firm’s IPO, in Hawthorne,…
Supreme Court Justices Skeptical of Trump’s Birthright Citizenship Order
Plus, SpaceX information IPO paperwork and Tim Prepare dinner takes WSJ inside Apple’s archives. Source link